Literature DB >> 9137432

CD44 is involved in migration but not spreading of astrocytoma cells in vitro.

B Radotra1, D McCormick.   

Abstract

Local tumour-cell invasiveness, which is a major morphological feature of astrocytomas, involves interactions between tumour cell and extracellular matrix (ECM) including adhesion, proteolysis, and migration of tumour cells through the locally modified microenvironment. These interactions are mediated by cell/cell and cell/substrate adhesion molecules. We have earlier demonstrated that the adhesion molecule CD44 is expressed on gliomas and plays a role in adhesive interactions between glioma cells and a wide range of ECM components. In the present in vitro study we have further investigated the possible role of CD44 in subsequent stages of cell/ECM interactions-spreading and migration, using the GCCM anaplastic astrocytoma cell line. We have demonstrated that cell spreading is more effective on fibronectin (FN) than hyaluronan (HA) with a mean cell perimeter of 185 microns when cells are grown on FN as compared to 66 microns on HA. Antibody blockade experiments indicated that CD44 is not involved in cell spreading on either substrate. In the in vitro migration assay the tumour cells displayed a 2.5 fold greater migration rate through HA-coated as compared to FN-coated polycarbonate membranes. Blocking of CD44 by specific monoclonal antibody resulted in an inhibition of migration by 56% on HA providing evidence that CD44 plays a role in migration of astrocytoma cells in vitro.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9137432

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  8 in total

Review 1.  "...those left behind." Biology and oncology of invasive glioma cells.

Authors:  M E Berens; A Giese
Journal:  Neoplasia       Date:  1999-08       Impact factor: 5.715

2.  Hyaluronate receptors mediating glioma cell migration and proliferation.

Authors:  Y Akiyama; S Jung; B Salhia; S Lee; S Hubbard; M Taylor; T Mainprize; K Akaishi; W van Furth; J T Rutka
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

3.  Perturbation of hyaluronan interactions inhibits malignant properties of glioma cells.

Authors:  Jeanine A Ward; Lei Huang; Huiming Guo; Shibnath Ghatak; Bryan P Toole
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

4.  Assessment of tumor cell invasion factors in gliomatosis cerebri.

Authors:  Christian Mawrin; Thomas Schneider; Raimund Firsching; Falk R Wiedemann; Knut Dietzmann; Antje Bornemann; Bernd F M Romeike; Bernd Sellhaus; Andreas von Deimling
Journal:  J Neurooncol       Date:  2005-06       Impact factor: 4.130

5.  The hyaluronan receptor RHAMM/IHABP in astrocytoma cells: expression of a tumor-specific variant and association with microtubules.

Authors:  Rixin Zhou; Xiao Wu; Omar Skalli
Journal:  J Neurooncol       Date:  2002-08       Impact factor: 4.130

6.  CD44H is expressed by cells of the oligodendrocyte lineage and by oligodendrogliomas in humans.

Authors:  Corinne Bouvier-Labit; Agnès Liprandi; Gilberte Monti; Jean François Pellissier; Dominique Figarella-Branger
Journal:  J Neurooncol       Date:  2002-11       Impact factor: 4.130

7.  Ccl5 establishes an autocrine high-grade glioma growth regulatory circuit critical for mesenchymal glioblastoma survival.

Authors:  Yuan Pan; Laura J Smithson; Yu Ma; Dolores Hambardzumyan; David H Gutmann
Journal:  Oncotarget       Date:  2017-05-16

Review 8.  The scrambled story between hyaluronan and glioblastoma.

Authors:  Matías Arturo Pibuel; Daniela Poodts; Mariángeles Díaz; Silvia Elvira Hajos; Silvina Laura Lompardía
Journal:  J Biol Chem       Date:  2021-03-17       Impact factor: 5.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.